Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Brigham and Women's Hospital
With
National Heart, Lung, and Blood Institute (NHLBI)
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults aged 21-80 years.
Participants with a previous diagnosis of moderate to severe obstructive sleep will be eligible to enroll and attend the baseline study. Patients with a total apnea-hypopnea index greater than 15 events/hr on the baseline study will be eligible for further participation.
You may not be if
Current treatment for obstructive sleep apnea (including CPAP, oral appliances, supplemental oxygen). Patients must be untreated prior to the baseline visit.
Use of medications that might depress respiration (including opioids, barbiturates, benzodiazepines, and Z drugs, including zolpidem, zopiclone, eszopiclone, and zaleplon).
Active use of non-prescription opioids (e.g., cocaine, methamphetamine)
Uncontrolled medical problem or major organ system disease, which, in the opinion of the investigators (PI and Co-Is), would interfere with the evaluation of the subject (e.g., uncontrolled hypertension, unstable coronary heart disease, etc.).
History of congestive heart failure, renal insufficiency, systemic neurological condition that could affect respiration.
Sleep disordered breathing or respiratory disorders other than obstructive sleep apnea:
* central sleep apnea (\>50% of respiratory events scored as central),
* chronic hypoventilation/hypoxemia (awake SaO2 \< 92% by oximetry) due to chronic obstructive pulmonary disease or other respiratory conditions.
Other sleep disorders: periodic limb movements (periodic limb movement arousal index \> 10/hr), narcolepsy, or parasomnias.
Patients unable or unwilling to use CPAP.
Insomnia or insufficient sleep (self-reported inability to sleep \>6 hrs night).